Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | See Remark | May 03, 2024 | May 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date May 03, 2024 · Filed May 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 345,188 |
Reported balance
After 2024-05-03 transaction · row 1
1 source rowRow 1 · 2024-05-03 · Sale · Disposed 798 · Balance 345,188 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2024 Filed May 7, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 798 | $37.13 | $29,632.93 |
DisclosureSEC source: 0001214659-24-008525 · marketforms-65751.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · See Remark 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,188 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| April 02, 2024 Filed Apr 4, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 327 | $32.74 | $10,704.67 |
DisclosureSEC source: 0001214659-24-006125 · marketforms-65452.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · See Remark 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,986 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 442 | $33.52 | $14,814.07 |
DisclosureSEC source: 0001214659-24-005018 · marketforms-65307.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · See Remark 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,313 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 549 | $37.43 | $20,549.07 |
DisclosureSEC source: 0001214659-24-004243 · marketforms-65106.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · See Remark 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,755 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 02, 2024 Filed Feb 6, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,043 | $36.59 | $38,163.37 |
DisclosureSEC source: 0001214659-24-002008 · marketforms-64520.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · See Remark 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,304 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 356 | $36.86 | $13,122.16 |
DisclosureSEC source: 0001214659-24-000251 · marketforms-63984.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 348,347 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 608 | $38.33 | $23,304.64 |
DisclosureSEC source: 0001214659-23-016695 · marketforms-63901.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 348,703 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 775 | $24.67 | $19,119.25 |
DisclosureSEC source: 0001214659-23-016152 · marketforms-63716.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,311 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 21:00 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 968 | $24.74 | $23,948.32 |
DisclosureSEC source: 0001214659-23-015497 · marketforms-63578.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,086 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 41,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-014607 · marketforms-63423.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,054 F3 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 2, 2023 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 2,731 | $17.31 | $47,273.61 |
DisclosureSEC source: 0001214659-23-014607 · marketforms-63423.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,599 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 19,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-014607 · marketforms-63423.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312,330 F1 · shares: Represents performance stock units for which target criteria was determined to have been met on November 2, 2023. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2024, subject to continued service or acceleration of vesting as provided in the award agreement. Read SEC document |
| October 24, 2023 Filed Oct 26, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 201 | $16.58 | $3,332.58 |
DisclosureSEC source: 0001214659-23-013921 · marketforms-63414.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,587 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 301 | $20.26 | $6,098.26 |
DisclosureSEC source: 0001214659-23-013061 · marketforms-62719.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,788 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 424 | $20.33 | $8,619.92 |
DisclosureSEC source: 0001214659-23-012535 · marketforms-62652.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,089 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 05, 2023 Filed Sep 7, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-012162 · marketforms-62550.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,513 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of September 25, 2023 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| August 18, 2023 Filed Aug 22, 2023 20:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 675 | $19.46 | $13,135.50 |
DisclosureSEC source: 0001214659-23-011600 · marketforms-62258.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,513 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 20:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 201 | $25.09 | $5,043.09 |
DisclosureSEC source: 0001214659-23-010005 · marketforms-62116.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,188 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 300 | $20.46 | $6,138.00 |
DisclosureSEC source: 0001214659-23-009247 · marketforms-62016.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,389 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 424 | $18.31 | $7,763.44 |
DisclosureSEC source: 0001214659-23-008705 · marketforms-61895.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,689 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| May 19, 2023 Filed May 23, 2023 20:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 675 | $13.03 | $8,795.25 |
DisclosureSEC source: 0001214659-23-007734 · marketforms-61589.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,113 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 201 | $13.63 | $2,739.63 |
DisclosureSEC source: 0001214659-23-006003 · marketforms-61310.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,788 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 300 | $15.08 | $4,524.00 |
DisclosureSEC source: 0001214659-23-004904 · marketforms-61134.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,989 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:03 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 418 | $16.51 | $6,901.18 |
DisclosureSEC source: 0001214659-23-004057 · marketforms-60919.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,289 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 21:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 675 | $22.52 | $15,201.00 |
DisclosureSEC source: 0001214659-23-002910 · marketforms-59579.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,707 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 21:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 232 | $28.74 | $6,667.68 |
DisclosureSEC source: 0001214659-23-001163 · marketforms-58283.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,382 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 21:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 292 | $24.05 | $7,022.60 |
DisclosureSEC source: 0001214659-23-000265 · marketforms-57986.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,614 F2 · shares: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 151 | $23.81 | $3,595.31 |
DisclosureSEC source: 0001214659-23-000265 · marketforms-57986.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,906 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 195 | $23.81 | $4,642.95 |
DisclosureSEC source: 0001214659-23-000265 · marketforms-57986.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,057 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 19, 2022 Filed Dec 21, 2022 22:01 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 19,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-015189 · marketforms-57909.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,252 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of December 19, 2022 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 21:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,275 | $24.90 | $31,747.50 |
DisclosureSEC source: 0001214659-22-014159 · marketforms-57656.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,631 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021. Read SEC document |
| November 18, 2022 Filed Nov 22, 2022 21:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 675 | $24.81 | $16,746.75 |
DisclosureSEC source: 0001214659-22-014112 · marketforms-57527.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,906 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| October 25, 2022 Filed Oct 26, 2022 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 379 | $29.55 | $11,199.45 |
DisclosureSEC source: 0001214659-22-012659 · marketforms-57356.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,581 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 201 | $29.08 | $5,845.08 |
DisclosureSEC source: 0001214659-22-012659 · marketforms-57356.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,960 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 318 | $36.14 | $11,492.52 |
DisclosureSEC source: 0001214659-22-011984 · marketforms-57252.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,161 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021 Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 131 | $35.24 | $4,616.44 |
DisclosureSEC source: 0001214659-22-011984 · marketforms-57252.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,479 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 169 | $35.24 | $5,955.56 |
DisclosureSEC source: 0001214659-22-011984 · marketforms-57252.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,610 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| August 22, 2022 Filed Aug 23, 2022 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,275 | $41.94 | $53,473.50 |
DisclosureSEC source: 0001214659-22-010496 · marketforms-56965.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,779 F2 · shares: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 675 | $42.81 | $28,896.75 |
DisclosureSEC source: 0001214659-22-010496 · marketforms-56965.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,054 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| July 25, 2022 Filed Jul 26, 2022 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 378 | $43.19 | $16,325.82 |
DisclosureSEC source: 0001214659-22-009194 · marketforms-56704.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,729 F2 · shares: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 201 | $43.52 | $8,747.52 |
DisclosureSEC source: 0001214659-22-009194 · marketforms-56704.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,107 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 318 | $36.79 | $11,699.22 |
DisclosureSEC source: 0001214659-22-008657 · marketforms-56621.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,308 F2 · shares: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 300 | $37.08 | $11,124.00 |
DisclosureSEC source: 0001214659-22-008657 · marketforms-56621.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,626 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| May 23, 2022 Filed May 24, 2022 20:43 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,275 | $37.04 | $47,226.00 |
DisclosureSEC source: 0001214659-22-007388 · marketforms-56317.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,926 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021 Read SEC document |
| May 20, 2022 Filed May 24, 2022 20:43 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 675 | $36.99 | $24,968.25 |
DisclosureSEC source: 0001214659-22-007388 · marketforms-56317.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,201 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 25, 2022 Filed Apr 26, 2022 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 378 | $33.98 | $12,844.44 |
DisclosureSEC source: 0001214659-22-005839 · marketforms-56023.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,876 F2 · shares: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021. Read SEC document |
| April 22, 2022 Filed Apr 26, 2022 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 201 | $34.21 | $6,876.21 |
DisclosureSEC source: 0001214659-22-005839 · marketforms-56023.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,254 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 318 | $53.61 | $17,047.98 |
DisclosureSEC source: 0001214659-22-004862 · marketforms-55949.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,455 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 300 | $52.91 | $15,873.00 |
DisclosureSEC source: 0001214659-22-004862 · marketforms-55949.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,773 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 23:03 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,280 | $52.66 | $67,404.80 |
DisclosureSEC source: 0001214659-22-003109 · marketforms-55520.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,073 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.